Pictured: Ellen Yorke and Karyn Goodman
In the Clinic
By Jim Stallard, MA, Writer/Editor  |  Wednesday, November 20, 2013

Memorial Sloan Kettering is exploring a precise form of high-dose radiation therapy for pancreatic cancer that could shorten treatment time and potentially be more effective.

Pictured: Oliver Zivanovic, Garrett Nash & Dennis Chi
In the Clinic
By Esther Napolitano, BS, Science Writer/Editor  |  Friday, November 15, 2013

Memorial Sloan Kettering experts are leading investigations of a procedure called hyperthermic intraperitoneal chemotherapy, also known as HIPEC.

Pictured: Farid Boulad
Cancer Guide
By Celia Gittelson, BA  |  Thursday, November 14, 2013

Memorial Sloan Kettering specialists provide state-of-the-art care for a range of pediatric blood disorders.

Pictured: Sarat Chandarlapaty
In the Lab
By Jim Stallard, MA, Writer/Editor  |  Friday, November 8, 2013

Memorial Sloan Kettering researchers have found genetic mutations that cause some breast cancers to develop resistance to hormone therapy.

Pictured: Michael Zelefsky
In the Clinic
By Esther Napolitano, BS, Science Writer/Editor  |  Wednesday, October 23, 2013

Memorial Sloan Kettering offers patients with prostate cancer a comprehensive package of the most advanced radiation therapy approaches that enable more-personalized and effective care.

Pictured: Sergio Giralt & Robin Roberts
Event
By Jim Stallard, MA, Writer/Editor  |  Thursday, October 17, 2013

Robin Roberts celebrated with more than 200 fellow stem cell transplant patients at Memorial Sloan Kettering’s annual Stem Cell Transplant Survivors Celebration.

Pictured: Lee Krug
Cancer Guide
By Andrea Peirce, BA, Writer/Editor  |  Friday, October 11, 2013

Memorial Sloan Kettering is recognized worldwide for its treatment of pleural and peritoneal mesothelioma.

Pictured: Vincent Laudone and James Eastham
Perspective
By James Eastham, MD and Vincent Laudone, MD
Friday, September 20, 2013

An earlier post about active surveillance as a management strategy for prostate cancer generated an engaged and meaningful discussion on this blog, especially about the risks of “doing nothing.” Here we take a closer look at the concept of risk.

Cancer Guide
By Jim Stallard, MA, Writer/Editor  |  Friday, September 13, 2013

Memorial Sloan Kettering specialists provide outstanding care for multiple myeloma and related plasma cell diseases.

Pictured: Lawrence Dauer
In the O.R.
By Media Staff  |  Tuesday, September 10, 2013

Memorial Sloan Kettering clinicians report on a successful first year of using a new procedure to pinpoint and remove small breast cancers.

Pictured: Mark Kris, Andreas Rimner, Nabil Pierre Rizk & Max Gomez
Video
By Helen Garey, MPH, Freelance Writer  |  Tuesday, September 3, 2013

In a recent CancerSmart talk focused on lung cancer, three Memorial Sloan Kettering experts described advances in diagnosis and treatment.

Pictured: Ian Ganly
Video
By Memorial Sloan Kettering  |  Wednesday, August 28, 2013

Dr. Ganly explains that experts in all disciplines – including medical oncology, radiation oncology, and surgery – work together as a team to deliver treatments offering the best results possible for patients.

Pictured: Robert J. Motzer
In the Clinic
By Maureen Salamon, BA, Freelance Writer  |  Thursday, August 22, 2013

An international study led by Memorial Sloan Kettering found that pazopanib (Votrient®) controls cancer as effectively as sunitinib (Sutent®) while improving patients’ quality of life.

Cancer Guide
By Andrea Peirce, BA, Writer/Editor  |  Friday, August 16, 2013

Memorial Sloan Kettering uses a multidisciplinary approach to provide leading-edge care to women with cervical cancer.

Pictured: Vincent Laudone  & James Eastham
Perspective
By James Eastham, MD and Vincent Laudone, MD
Wednesday, August 14, 2013

Active surveillance is the most appropriate management strategy for many men with prostate cancer, but often this option is never mentioned.

Center News

Stay Informed

Get the latest information about cancer care and research every month.